Brief Description
Tenaya Therapeutics is shaping the future of heart disease treatment driven by a mission to discover, develop, and deliver curative therapies that address the underlying drivers of heart disease. Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three platforms: Gene Therapy, Cellular Regeneration, and Precision Medicine. The company was founded by leading cardiology researchers at the Gladstone Institutes and UT Southwestern, and backed by a top-tier syndicate of investors.
Timeline
- 2016. Company founded
- 2021. Initial public offering on the Nasdaq stock exchange under the ticker symbol TNYA
Inventors
Bruce Conklin, Kevin Healy, Nathaniel Huebsch, Peter Loskill